远征品牌怎么样 申请店铺

我要投票 远征在兽药行业中的票数:631 更新时间:2026-01-23
远征是哪个国家的品牌?「远征」是 河北远征药业有限公司 旗下著名品牌。该品牌发源于河北省石家庄市,由创始人穆董在1972年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力远征品牌出海!将品牌入驻外推网,定制远征品牌推广信息,可以显著提高远征产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

远征怎么样

兽药制剂行业知名品牌,集兽药产品研发、生产经营、技术服务于一体的高新技术企业


河北远征药业有限公司(以下简称远征药业)是一家集兽药产品研发、生产经营、技术服务于一体的高科技综合性兽药企业。

远征药业总部位于河北省石家庄市,现有资产总额6亿多元,员工1000余人,包括河北远征药业有限公司、河北远征禾木药业有限公司、远征(乌干达)制药有限公司、河北远征商贸有限公司、河北福沐贸易有限公司等五家全资或控股子公司。

目前,远征药业拥有三个厂区,12个现代化生产车间,22条GMP生产线。公司投入巨资先后引进国内先进的全自动粉针(水针)分装及包装设备、联动灌装设备等500多台套,是目前国内生产规模较大、设备较为先进的兽用制剂生产基地,公司现代化的生产设备和基础设施达到了世界水平。

公司依托先进的技术设备,可生产粉针、水针、粉剂、散剂、片剂、颗粒剂、预混剂、灌注剂、消毒液、口服液、原料药、饲料预混剂等十二大系列共200多个产品。

远征药业的粉针车间在1997年通过GMP认证,是全国兽药制剂行业通过农业部GMP认证的企业。

公司拥有“盐酸沃尼妙林”等国家二类新兽药6个,三四类新兽药8个。公司通过加大与国内外知名兽医专家的学术交流,加强与国内多所知名高等院校的合作,使公司产品结构不断得到优化,产品科技含量持续提高,逐步形成了研制一代,储备一代,生产一代的研发体系。

远征药业始终奉行“以诚信树品牌,以服务促销售”的市场开发战略。随着“远征”品牌影响力的不断提升,吸引了众多国内外客户的关注,多家大型养殖集团纷纷来远征药业考察。国内知名的温氏、中粮、蒙牛、立华、正大等几十家大型养殖集团都已与远征药业建立了长期的、稳固的合作伙伴关系。


Hebei expeditionary Pharmaceutical Co., Ltd. (hereinafter referred to as expeditionary pharmaceutical) is a high-tech comprehensive veterinary pharmaceutical enterprise integrating the R & D, production and operation, and technical services of veterinary pharmaceutical products. The headquarter of expeditionary pharmaceutical is located in Shijiazhuang City, Hebei Province, with total assets of more than 600 million yuan and more than 1000 employees, including five wholly-owned or holding subsidiaries, including Hebei expeditionary Pharmaceutical Co., Ltd., Hebei expeditionary Hemu Pharmaceutical Co., Ltd., expeditionary (Uganda) Pharmaceutical Co., Ltd., Hebei expeditionary commerce Co., Ltd., and Hebei fumu Trading Co., Ltd. At present, the company has three factories, 12 modern production workshops and 22 GMP production lines. The company has invested a lot of money to introduce more than 500 sets of domestic advanced fully automatic powder injection (water needle) sub packaging and packaging equipment, linkage filling equipment, etc. it is currently a production base of veterinary preparations with large production scale and advanced equipment in China, and its modern production equipment and infrastructure have reached the world level. Relying on advanced technology and equipment, the company can produce more than 200 products in 12 series, including powder injection, water injection, powder, powder, tablet, granule, premix, perfusion, disinfectant, oral liquid, API, feed premix, etc. The powder injection workshop of expeditionary pharmaceutical industry passed GMP certification in 1997. It is an enterprise that has passed GMP certification of the Ministry of agriculture in the national veterinary pharmaceutical industry. The company has 6 class II new veterinary drugs and 8 class III and IV new veterinary drugs, such as "vorimilin hydrochloride". Through increasing academic exchanges with well-known veterinary experts at home and abroad, and strengthening cooperation with a number of well-known institutions of higher learning at home, the company's product structure has been continuously optimized, and the scientific and technological content of products has been continuously improved, gradually forming a research and development system of one generation development, one generation reserve, and one generation production. Expeditionary pharmaceutical always pursues the market development strategy of "building brand with integrity and promoting sales with service". With the continuous improvement of the brand influence of expeditionary, it has attracted the attention of many customers at home and abroad, and many large-scale breeding groups have come to inspect the pharmaceutical industry. Dozens of domestic famous large-scale breeding groups, such as Wenshi, COFCO, Mengniu, Lihua and Zhengda, have established long-term and stable partnership with expeditionary pharmaceutical industry.

本文链接: https://brand.waitui.com/83f80b8c3.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

帅丰电器:预计2025年净亏损4300万元-6200万元,公司股票可能被实施退市风险警示

36氪获悉,帅丰电器公告,预计2025年年度实现利润总额-5700万元到-3800万元,净利润-6200万元到-4300万元,扣除非经常性损益后的净利润-7400万元到-5500万元。预计2025年年度实现营业收入21000万元到25000万元,扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入为20000万元到24000万元,低于3亿元。根据《股票上市规则》,公司股票可能被上海证券交易所实施退市风险警示。

2小时前

郑州煤电:超化煤矿资源濒临枯竭,停止生产

36氪获悉,郑州煤电公告,公司所属超化煤矿核定产能120万吨/年,资源濒临枯竭,继续开采面临技术瓶颈与安全风险,不具有开采经济价值,停止生产活动。经公司财务部门初步测算,预计需计提减值准备3.11亿元,将直接减少2025年度归属于上市公司股东净利润3.11亿元。

2小时前

阿里巴巴-W遭南向资金净卖出14.90亿港元

南向资金今日净卖出16.01亿港元,阿里巴巴-W、中国移动、长飞光纤光缆分别遭净卖出14.90亿港元、6.22亿港元、1.38亿港元。净买入方面,泡泡玛特、小米集团-W、腾讯控股净买入额位列前三,分别获净买入7.47亿港元、6.08亿港元、2.40亿港元。(第一财经)

2小时前

晶方科技:2025年净利同比预增44.41%-52.32%

36氪获悉,晶方科技发布2025年业绩预告。报告显示,预计2025年年度归属于上市公司股东的净利润为3.65亿元至3.85亿元,同比增长44.41%至52.32%。

2小时前

微软服务中断致Outlook邮箱瘫痪数小时

微软周四表示,正在调查一起服务中断事件。受此影响,北美地区的Office 365系列应用(包括Outlook邮箱服务和Teams即时通讯软件)全天无法正常使用。该公司称,已注意到部分用户无法通过Outlook收发邮件的问题。(新浪财经)

2小时前

本页详细列出关于远征的品牌信息,含品牌所属公司介绍,远征所处行业的品牌地位及优势。
咨询